Sildenafil for the Prevention of Right Heart Failure Following Continuous-Flow Left Ventricular Assist Device Implantation (The REVAD Study)
Phase of Trial: Phase III
Latest Information Update: 06 Oct 2018
At a glance
- Drugs Sildenafil (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms The REVAD Study
- 02 May 2018 Planned primary completion date changed from 1 Mar 2019 to 1 Jun 2019.
- 02 May 2018 Status changed from not yet recruiting to recruiting.
- 27 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Mar 2018.